Plasma amino-terminal pro–B-type natriuretic peptide quantification in hypertrophic cardiomyopathy

• Published in: The American heart journal Vol. 150; no. 6; pp. 1228 - 1232
• Main Authors: Arteaga, Edmundo, Araujo, Aloir Queiroz, Buck, Paula, Ianni, Barbara Maria, Rabello, Rogerio, Mady, Charles
• Format: Journal Article
• Language: English
• Published: New York, NY Mosby, Inc 01.12.2005; Elsevier; Elsevier Limited
• Subjects: Adult; Biological and medical sciences; Biomarkers - blood; Cardiology; Cardiology. Vascular system; Cardiomyopathy; Cardiomyopathy, Hypertrophic - blood; Cardiomyopathy, Hypertrophic - diagnostic imaging; Cardiomyopathy, Hypertrophic - physiopathology; Cardiovascular disease; Cross-Sectional Studies; Echocardiography; Female; Flow velocity; Heart; Heart Atria - anatomy & histology; Heart failure; Humans; Ischemia; Male; Medical sciences; Multivariate analysis; Myocarditis. Cardiomyopathies; Natriuretic Peptide, Brain - blood; Peptide Fragments - blood; Peptides; Plasma; Population; Reference Values; Studies; Variables; Brain natriuretic peptide; Quantization; Cardiovascular disease; Myocardial disease; Phlebology; Blood plasma; Heart disease; Hypertrophic cardiomyopathy; Qualitative analysis; Circulatory system; Cardiology; Aminoacid sequence; Quantitative analysis

Plasma B-type natriuretic peptide (BNP) is a sensitive functional marker in heart disease including hypertrophic cardiomyopathy (HCM). The utility of plasma amino-terminal pro-BNP (NT-proBNP) quantification in heart disease has been investigated, but there are no published data regarding this test i...